Daniel D. Von Hoff

481 total citations
8 papers, 400 citations indexed

About

Daniel D. Von Hoff is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel D. Von Hoff has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel D. Von Hoff's work include Biochemical and Molecular Research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer therapeutics and mechanisms (1 paper). Daniel D. Von Hoff is often cited by papers focused on Biochemical and Molecular Research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer therapeutics and mechanisms (1 paper). Daniel D. Von Hoff collaborates with scholars based in United States and France. Daniel D. Von Hoff's co-authors include S P Balcerzak, Charles A. Coltman, John J. Hutton, Joe C. Files, J Marty, Steve Weitman, Jacques Jolivet, Susan G. Hilsenbeck, S. Gail Eckhardt and Eric K. Rowinsky and has published in prestigious journals such as Cancer, European Journal of Cancer and Cancer and Metastasis Reviews.

In The Last Decade

Daniel D. Von Hoff

8 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel D. Von Hoff United States	6	160	145	123	104	75	8	400
Dominique Cazals France	9	247 1.5×	40 0.3×	138 1.1×	143 1.4×	98 1.3×	11	525
Silpa Nuthalapati United States	12	213 1.3×	97 0.7×	151 1.2×	42 0.4×	37 0.5×	28	376
Christiane Mounier France	8	178 1.1×	78 0.5×	212 1.7×	158 1.5×	47 0.6×	14	464
Lawrence Panasci Canada	14	416 2.6×	61 0.4×	311 2.5×	57 0.5×	46 0.6×	32	656
Dan Costin United States	7	297 1.9×	276 1.9×	202 1.6×	185 1.8×	101 1.3×	21	559
Anand Pathak United States	11	134 0.8×	43 0.3×	153 1.2×	39 0.4×	37 0.5×	25	395
J. H. Doroshow United States	14	247 1.5×	25 0.2×	187 1.5×	56 0.5×	99 1.3×	30	543
Gerd Leder Germany	11	287 1.8×	34 0.2×	212 1.7×	38 0.4×	93 1.2×	13	526
RJ Scheper Netherlands	10	322 2.0×	41 0.3×	281 2.3×	74 0.7×	57 0.8×	16	557
Alexander S. Thomas United States	10	317 2.0×	347 2.4×	268 2.2×	189 1.8×	146 1.9×	21	681

Countries citing papers authored by Daniel D. Von Hoff

Since Specialization

Citations

This map shows the geographic impact of Daniel D. Von Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Von Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Von Hoff more than expected).

Fields of papers citing papers by Daniel D. Von Hoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Von Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Von Hoff. The network helps show where Daniel D. Von Hoff may publish in the future.

Co-authorship network of co-authors of Daniel D. Von Hoff

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Von Hoff. A scholar is included among the top collaborators of Daniel D. Von Hoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Von Hoff. Daniel D. Von Hoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Benjamin, David J. & Daniel D. Von Hoff. (2024). The emerging role of GLP-1 receptor agonists in treating or preventing cancer. Cancer Drug Resistance. 7(4). 49–49. 2 indexed citations

2.

Weitman, Steve, et al.. (2000). The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts.. PubMed. 6(4). 1574–8. 47 indexed citations

3.

Britten, Carolyn D., Susan G. Hilsenbeck, S. Gail Eckhardt, et al.. (1999). Enhanced antitumor activity of 6-hydroxymethylacylfulvene in combination with irinotecan and 5-fluorouracil in the HT29 human colon tumor xenograft model.. PubMed. 59(5). 1049–53. 61 indexed citations

4.

Hoff, Daniel D. Von, et al.. (1996). Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. Investigational New Drugs. 14(3). 265–270. 33 indexed citations

5.

Ross, Michael J., et al.. (1993). In vitro activity of the benzotriazene dioxide SR 4233 against human tumour colony-forming units. European Journal of Cancer. 29(3). 423–425. 4 indexed citations

6.

Hoff, Daniel D. Von, Richard A. Kronmal, Sydney E. Salmon, et al.. (1991). A southwest oncology group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer. 67(1). 20–27. 54 indexed citations

7.

Hoff, Daniel D. Von. (1988). Human tumor cloning assays: Applications in clinical oncology and new antineoplastic agent development. Cancer and Metastasis Reviews. 7(4). 357–371. 49 indexed citations

8.

Coltman, Charles A., et al.. (1988). Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.. PubMed. 30(5-6). 457–9. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact